HC Wainwright Has Pessimistic Outlook of FULC Q1 Earnings
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) – Research analysts at HC Wainwright lowered their Q1 2025 earnings estimates for shares of Fulcrum Therapeutics in a report released on Wednesday, February 26th. HC Wainwright analyst A. Fein now anticipates that the company will post earnings per share of ($0.27) for the quarter, down from their […]
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) – Research analysts at HC Wainwright lowered their Q1 2025 earnings estimates for shares of Fulcrum Therapeutics in a report released on Wednesday, February 26th. HC Wainwright analyst A. Fein now anticipates that the company will post earnings per share of ($0.27) for the quarter, down from their […]